Zomedica Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9.37	9.02	7.02	12.95	27.4	194.95
Short-Term Investments	38.14	44.24	64.33	77.55	87.69	-
Cash & Short-Term Investments	47.51	53.26	71.35	90.5	115.09	194.95
Cash Growth	-25.31%	-25.36%	-21.15%	-21.37%	-40.96%	214.48%
Accounts Receivable	4.43	3.01	2.42	1.2	0.6	0.32
Other Receivables	0.37	0.44	0.65	1	1.27	0.45
Receivables	4.8	3.46	3.07	2.2	1.86	0.77
Inventory	5.88	5.55	5.06	5.12	2.75	2.85
Prepaid Expenses	1.85	1.79	2.29	2.06	3.8	1.84
Total Current Assets	60.03	64.04	81.77	99.88	123.5	200.41
Property, Plant & Equipment	22.32	22.94	26.2	25.29	9.17	2.87
Long-Term Investments	-	-	-	10.01	40.71	-
Goodwill	-	-	45.56	61.58	63.98	43.29
Other Intangible Assets	37.98	38.81	52.54	55.36	41.8	33.18
Other Long-Term Assets	1.21	1.25	1.29	1.07	0.45	0.66
Total Assets	121.53	127.04	207.36	253.2	279.61	280.4
Accounts Payable	2.2	1.72	1.93	2.07	6.7	3.23
Accrued Expenses	4.88	6.2	6.1	5.35	-	-
Current Portion of Leases	0.72	0.72	0.52	0.92	0.64	0.42
Current Income Taxes Payable	0.19	0.25	0.12	0.07	0.19	0.24
Current Unearned Revenue	0.35	0.37	0.33	0.28	0.21	0.2
Other Current Liabilities	0.23	0.2	0.34	0.36	0.08	0.26
Total Current Liabilities	8.56	9.45	9.33	9.03	7.81	4.34
Long-Term Leases	1.3	1.47	1.29	1.81	1.1	0.96
Long-Term Unearned Revenue	0.27	0.23	0.22	0.25	0.18	0.14
Long-Term Deferred Tax Liabilities	0.05	0.03	0.46	1.14	1.25	3.71
Other Long-Term Liabilities	0.42	0.47	0.4	0.94	1.88	0.36
Total Liabilities	10.59	11.64	11.7	13.18	12.22	9.51
Common Stock	380.97	380.97	380.97	380.97	380.97	380.96
Additional Paid-In Capital	34.18	34.04	32.52	29.93	23.67	9.31
Retained Earnings	-304.31	-299.77	-217.92	-170.93	-136.4	-119.39
Comprehensive Income & Other	0.1	0.16	0.09	0.05	-0.84	0
Total Common Equity	110.95	115.4	195.66	240.02	267.39	270.89
Shareholders' Equity	110.95	115.4	195.66	240.02	267.39	270.89
Total Liabilities & Equity	121.53	127.04	207.36	253.2	279.61	280.4
Total Debt	2.01	2.18	1.81	2.73	1.74	1.38
Net Cash (Debt)	45.5	51.07	69.54	87.77	113.35	193.57
Net Cash Growth	-25.33%	-26.56%	-20.77%	-22.57%	-41.44%	221.96%
Net Cash Per Share	0.05	0.05	0.07	0.09	0.12	0.20
Filing Date Shares Outstanding	979.95	979.95	979.95	979.95	979.95	979.9
Total Common Shares Outstanding	979.95	979.95	979.95	979.95	979.95	979.9
Working Capital	51.47	54.59	72.44	90.85	115.69	196.07
Book Value Per Share	0.11	0.12	0.20	0.24	0.27	0.28
Tangible Book Value	72.97	76.59	97.57	123.07	161.61	194.42
Tangible Book Value Per Share	0.07	0.08	0.10	0.13	0.16	0.20
Machinery	16.84	16.57	17.03	10.44	6.85	1.73
Construction In Progress	6.18	6.42	7.89	12.48	0.69	0.42
Leasehold Improvements	2.85	2.85	3.09	1.95	1.24	0.29

Source: S&P Global Market Intelligence. Standard template. Financial Sources.